tamsulosin hydrochloride synthon 0.4 mg gél. lib. modif.
synthon b.v. - chlorhydrate de tamsulosine 0,4 mg - gélule à libération modifiée - 0,4 mg - chlorhydrate de tamsulosine 0.4 mg - tamsulosin
levamisole hydrochloride 80 % kela
kela sa-nv - chlorhydrate de lévamisole 800 mg/g - poudre orale - chlorhydrate de lévamisole 800 mg/g - levamisole - porc
sevelamer hydrochloride waymade 400 mg compr. pellic.
waymade b.v. - chlorhydrate de sevelamer 400 mg - comprimé pelliculé - 400 mg - chlorhydrate de sevelamer 400 mg - sevelamer
sevelamer hydrochloride waymade 800 mg compr. pellic.
waymade b.v. - chlorhydrate de sevelamer 800 mg - comprimé pelliculé - 800 mg - chlorhydrate de sevelamer 800 mg - sevelamer
infinito®
bayer ag - propamocarbe hydrochloride; fluopicolide - suspension concentrée (sc) - 55.6 %625 g/l; 5.56 %62.5 g/l; - 625 g/l hydrochlorure de propamocarbe; 62,5 g/l fluopicolide - fongicide ;
bupivacaine hydrochloride, 5mg/ml, ampoule injectable, 10x4ml
ihdlife inc, - bupivacaine hydrochloride bp - ampoule injectable - 5mg/ml
gutron 5 mg/2 ml, solution injectable (iv, im) en ampoule
nycomed austria gmbh - chlorhydrate de midodrine - solution - 5 mg - composition pour une ampoule de 2 ml > chlorhydrate de midodrine : 5 mg
infinito
bayer (schweiz) ag - propamocarbe; fluopicolide - scsuspension concentrée - 46.3 %524 g/l; [sous forme de 55.6 % de propamocarbe hydrochloride (625.0 g/l)]; 5.53 %62.5 g/l; - fongicide ;
tamsulosin hydrochloride synthon 0.4 mg gél. lib. modif.
synthon b.v. - chlorhydrate de tamsulosine 0,4 mg - gélule à libération modifiée - tamsulosin
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - la vildagliptine, la metformine chlorhydrate de - diabète sucré, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 et 5. 1 pour les données disponibles sur différentes combinaisons).